As genome editing therapies move through clinical trials to regulatory approval, scientists continue the quest for the holy ...
Life Biosciences has received FDA clearance to begin a first-in-human Phase 1 clinical trial of ER-100, a gene therapy ...
A new study from researchers at The University of Texas MD Anderson Cancer Center has uncovered how one of the most common ...
HOUSTON, JULY 1, 2026 ― A new study from researchers at The University of Texas MD Anderson Cancer Center has uncovered how one of the most common ...